Form 8-K - Current report:
SEC Accession No. 0001104659-25-083402
Filing Date
2025-08-27
Accepted
2025-08-27 07:01:35
Documents
12
Period of Report
2025-08-27
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2524474d1_8k.htm   iXBRL 8-K 74926
  Complete submission text file 0001104659-25-083402.txt   245238

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA btai-20250827.xsd EX-101.SCH 3047
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE btai-20250827_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE btai-20250827_pre.xml EX-101.PRE 22380
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2524474d1_8k_htm.xml XML 3562
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

EIN.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)